(Q28308220)

English

Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas

scientific article

In more languages

Statements

scholarly article

0 references

Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas (English)

0 references

1 reference

based on heuristic

inferred from title

9

object named as

Yasushi Yatabe

0 references

author name string

Yasushi Matsuyama

1

0 references

Motoshi Suzuki

2

0 references

Chinatsu Arima

3

0 references

Qin Miao Huang

4

0 references

Shuta Tomida

5

0 references

Toshiyuki Takeuchi

6

0 references

Ryoji Sugiyama

7

0 references

Yasutomo Itoh

8

0 references

Hidemi Goto

10

0 references

Takashi Takahashi

11

0 references

language of work or name

0 references

publication date

April 2011

0 references

Molecular Carcinogenesis

0 references

50

0 references

4

0 references

301-9

0 references

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

The proteasome: a suitable antineoplastic target

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Structural features of the 26 S proteasome complex

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Incorporating bortezomib into the treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

let-7 regulates Dicer expression and constitutes a negative feedback loop

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

cDNA cloning and functional analysis of the p97 subunit of the 26S proteasome, a polypeptide identical to the type-1 tumor-necrosis-factor-receptor-associated protein-2/55.11

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Mts4, a non-ATPase subunit of the 26 S protease in fission yeast is essential for mitosis and interacts directly with the ATPase subunit Mts2.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Signal integration by JNK and p38 MAPK pathways in cancer development

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Intrinsic tumour suppression

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

The targeting of the proteasomal regulatory subunit S2 by adenovirus E1A causes inhibition of proteasomal activity and increased p53 expression

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

The proteasome: overview of structure and functions

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Proteasome subunit Rpn1 binds ubiquitin-like protein domains

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

A gene-expression signature to predict survival in breast cancer across independent data sets.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Large-scale cDNA transfection screening for genes related to cancer development and progression

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

EGFR mutation is specific for terminal respiratory unit type adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

TTF-1 expression in pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis

1 reference

https://api.crossref.org/works/10.1002%2FMC.20632

21 January 2018

Identifiers

10.1002/MC.20632

0 references

release_a6jt3jf2kndv7ftgdv4txcfm6a

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28308220&oldid=1590520305"